Walleye Capital
TMO icon

Walleye Capital’s Thermo Fisher Scientific TMO Stock Holding History

Walleye Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$58M Buy
85,877
+85,665
+40,408% +$50.9M 0.05% 333
2026
Q2 		$106K Sell
212
-42,827
-100% -$20.6M ﹤0.01% 3867
2026
Q1 		$21.2M Buy
43,039
+28,793
+202% +$15.6M 0.09% 176
2025
Q4 		$8.25M Buy
14,246
+9,184
+181% +$5.19M 0.03% 785
2025
Q3 		$2.46M Buy
5,062
+2,671
+112% +$1.24M 0.01% 1425
2025
Q2 		$969K Sell
2,391
-21,704
-90% -$9.07M ﹤0.01% 2076
2025
Q1 		$12M Sell
24,095
-28,341
-54% -$15.3M 0.05% 371
2024
Q4 		$27.3M Buy
52,436
+5,938
+13% +$3.26M 0.07% 235
2024
Q3 		$28.8M Buy
46,498
+16,241
+54% +$9.6M 0.06% 228
2024
Q2 		$16.7M Buy
30,257
+4,188
+16% +$2.4M 0.03% 443
2024
Q1 		$15.2M Sell
26,069
-25,833
-50% -$14.5M 0.03% 568
2023
Q4 		$27.5M Buy
51,902
+3,958
+8% +$1.92M 0.06% 234
2023
Q3 		$24.3M Buy
+47,944
New +$25.5M 0.06% 195
2023
Q2 		– Sell
-300
Closed -$162K – 4882
2023
Q1 		$173K Buy
+300
New +$169K ﹤0.01% 2575

Other funds holding TMO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Walleye Capital's TMO Position: Q3 2026 in Review

Walleye Capital increased its Thermo Fisher Scientific (TMO) stake by 40,408% in Q3 2026, buying an estimated $50.9M and bringing the position to 85,877 shares worth $58M. The position accounts for 0.05% of the portfolio, ranked #333.

Walleye Capital first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Walleye Capital held 85,877 shares of Thermo Fisher Scientific worth $58M as of Q3 2026.
  • Walleye Capital bought 85,665 Thermo Fisher Scientific shares in Q3 2026, an estimated $50.9M.
  • Thermo Fisher Scientific made up 0.05% of Walleye Capital's portfolio in Q3 2026, its #333 holding.
  • Walleye Capital first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.